Halozyme Therapeutics Inc (HALO) Business News Nov. 07, 2025, 13:31 UTC Halozyme - FDA Approved DARZALEX Faspro® for Adult Patients with High-Risk Smoldering Multiple Myeloma Full text
There are no comments here yet...